Incadronate Disodium

英卡膦酸二钠

Report date: 2022/05/18 17:41:12
NME

Base Information

Drug NameIncadronate Disodium
Drug Alias Name因卡膦酸二钠Incadronate因卡膦酸Incadronic acid disodium saltCimadronate sodium +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFarnesyl diphosphate synthase inhibitors
TargetsFarnesyl diphosphate synthase
Therapy Area/IndicationsPainHypercalcemiaPeriodontitis +[4] 
Global Approved IndicationsPainHypercalcemiaPeriodontitis +[4] 
Approved Indications in ChinaOsteoporosis
Original Approved Country/TerritoryJapan
Original Approved Date1997/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncLivzon(Group) Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsPainHypercalcemiaPeriodontitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeM05BA
Related LinksDrugBankKEGG